跳至主要内容
临床试验/ISRCTN83673558
ISRCTN83673558已完成不适用

Combined aspirin, clopidogrel and dipyridamole versus aspirin alone in stroke secondary prevention: a safety, tolerability and feasibility study

niversity of Nottingham (UK)0 个研究点目标入组 51 人开始时间: 2005年10月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 years or older
  • 2. Ischaemic stroke on computed tomography (CT)/magnetic resonance imaging (MRI) within 5 years
  • 3. Previous transient ischemic attack (TIA) within 5 years
  • 4. Written informed consent from patient
  • 5. In sinus ryhthm or atrial fibrillation but not suitable for anticoagulation

排除标准

  • 1. Thrombocytopenia
  • 2. Severe hypertension
  • 3. Previous cerebral haemorrhage
  • 4. Hypersensitivity or intolerance to aspirin, dipyridamole or clopidogrel
  • 5. Any history of peptic ulcer or gastrointestinal bleeding
  • 6. Severe concomitant medical conditions including acquired immunodeficiency syndrome (AIDS) or cancer
  • 7. Pregnancy or breast feeding
  • 8. Patients needing or already receiving anticoagulant or non-steroidal anti-inflammatory drugs (NSAIDs) other than aspirin therapy

研究者

发起方
niversity of Nottingham (UK)

相似试验